Scientific Program

Filter Results:

  • +

    WS 01 - IASLC Supporting the Implementation of Quality Assured Global CT Screening Workshop (By Invitation Only) (ID 632)

    • Type: Workshop
    • Track: Radiology/Staging/Screening
    • Moderators:
    • +

      WS 01.01 - Welcome and Aims of Workshop (ID 10613)

      08:30 - 08:40 AM  |  Presenting Author(s): John Kirkpatrick Field, James L Mulshine

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.02 - Session 1 (ID 10640)

      08:40 - 08:40 AM  |  Presenting Author(s): John Kirkpatrick Field, Harry J De Koning

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.03 - CT Screened Lung Cancer Survivor: A Patients Prospective on Lung Cancer Screening (ID 10641)

      08:40 - 08:55 AM  |  Presenting Author(s): Andrea Katalin Borondy Kitts

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.04 - Tobacco Cessation in the CT Screening Setting – Is It Working? (ID 10642)

      08:55 - 09:10 AM  |  Presenting Author(s): Jamie Ostroff

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.05 - How Do We Engage the High Risk Population in Lung Cancer Screening? - Primary Care Perspective in UK (ID 10643)

      09:10 - 09:17 AM  |  Presenting Author(s): Martin Ledson

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.06 - How Do We Engage the High Risk Population in Lung Cancer Screening? - Strategy for Engaging Participants (ID 10644)

      09:17 - 09:25 AM  |  Presenting Author(s): Angela Meredith Criswell

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.07 - Modeling Smoking Trends and CT Screening to 2060 (ID 10645)

      09:25 - 09:40 AM  |  Presenting Author(s): Rafael Meza  |  Author(s): J. Jeon

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.08 - Discussion (ID 10646)

      09:40 - 09:50 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.09 - Session 2: Radiological Imaging – Quality Assurance and Training (ID 10647)

      09:50 - 09:50 AM  |  Presenting Author(s): David Raymond Baldwin, Matthijs Oudkerk, Ning Wu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.10 - Reviews of International Guidelines for Management of Pulmonary Nodules (i.e. NCCN/ LUNG-RADS, BTS, Fleischner IELCAP, etc.) (ID 10648)

      09:50 - 10:05 AM  |  Presenting Author(s): David F Yankelevitz

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.11 - Planning for European Registries for CT Screened Images – What Are Their Objectives? (ID 10649)

      10:05 - 10:20 AM  |  Presenting Author(s): Matthijs Oudkerk  |  Author(s): M.A. Heuvelmans

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.12 - Planning for USA Registries for CT Screened Images – What Are Their Objectives? (ID 10650)

      10:20 - 10:35 AM  |  Presenting Author(s): Ricardo S Avila  |  Author(s): Claudia I Henschke, David F Yankelevitz

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.13 - Next Generation CT Scanners for Lung Cancer Screening – Way Forward (ID 10651)

      10:35 - 10:50 AM  |  Presenting Author(s): Sebastian Schmidt

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.14 - Discussion (ID 10652)

      10:50 - 11:00 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.15 - Tea/Coffee Break (ID 10653)

      11:00 - 11:30 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.16 - Session 3: Added Value to Lung Cancer CT Screening Programs (ID 10654)

      11:30 - 11:30 AM  |  Presenting Author(s): Kwun M Fong, Nir Peled

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.17 - The Potential of Radio-omics and Deep Learning (ID 10655)

      11:30 - 11:45 AM  |  Presenting Author(s): Anthony Reeves

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.19 - Cardiologists View of Utilising Calcium Scoring in Lung Cancer Screening Trials (ID 10657)

      12:00 - 12:15 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.20 - Lunch (ID 10658)

      12:15 - 01:35 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.21 - Session 4: The Concept of Collaboration in CT Screening Programs (ID 10659)

      01:35 - 01:35 PM  |  Presenting Author(s): David F Yankelevitz, Angela Meredith Criswell

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.22 - Quality Control Throughout Lung Cancer Management (ID 10662)

      01:35 - 01:43 PM  |  Presenting Author(s): David Gierada

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.23 - Radiology Leading But Integrated? (ID 10664)

      01:43 - 01:51 PM  |  Presenting Author(s): David F Yankelevitz

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.24 - Designs of Possible Biomarkers for Future Screening Programs? (ID 10665)

      01:51 - 01:59 PM  |  Presenting Author(s): John Kirkpatrick Field  |  Author(s): M.P. Davies

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.25 - Smoking Cessation – How to Integrate? (ID 10670)

      01:59 - 02:07 PM  |  Presenting Author(s): Jamie Ostroff

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.26 - COPD Integration into CT Screening – Patient Benefit? (ID 10671)

      02:07 - 02:15 PM  |  Presenting Author(s): Javier J. Zulueta

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.27 - Surgical Integration at the Earliest Stages Planned CT Screening? (ID 10672)

      02:15 - 02:23 PM  |  Presenting Author(s): Jesper Holst Pedersen

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.28 - Discussion (ID 10673)

      02:23 - 02:40 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.29 - Session 5: The Current Global Implementation of CT Lung Cancer Screening Programs (ID 10674)

      02:40 - 02:40 PM  |  Presenting Author(s): Shuji Sakai, Robert Smith

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.30 - China (ID 10675)

      02:40 - 02:50 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.31 - Japan (ID 10676)

      02:50 - 03:00 PM  |  Presenting Author(s): Kazuto Ashizawa

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.32 - Canada & Australia (ID 10677)

      03:00 - 03:20 PM  |  Presenting Author(s): Kwun M Fong

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.33 - EU Commission Recommendations on Screening (ID 10678)

      03:20 - 03:30 PM  |  Presenting Author(s): Denis Horgan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.34 - CT Screening in USA – Current Issues around Implementation – Lessons to be Learnt (ID 10679)

      03:30 - 03:40 PM  |  Presenting Author(s): James L Mulshine

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.35 - USA Roundtable Update (ID 10680)

      03:40 - 03:50 PM  |  Presenting Author(s): Ella Kazerooni

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.36 - NELSON – Update (ID 10681)

      03:50 - 04:00 PM  |  Presenting Author(s): Harry J De Koning

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.37 - Tea/Coffee Break (ID 10682)

      04:00 - 04:20 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.38 - Session 6: What Priorities and Recommendations Should the IASLC Executive Focus On: How They Can Support Leadership in this Area of Lung Cancer (Round Table Discussion) (ID 10683)

      04:20 - 06:00 PM  |  Presenting Author(s): John Kirkpatrick Field, James L Mulshine

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.39 - 1. How Do We Ensure Smoking Cessation is Integrated into Best Practice Screening? (ID 10684)

      06:00 - 06:00 PM  |  Presenting Author(s): Angela Meredith Criswell

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.40 - 2. How Do We Optimise an International Approach to Pulmonary Nodules Management? (ID 10685)

      06:00 - 06:00 PM  |  Presenting Author(s): Matthijs Oudkerk

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.41 - 3. How to Talk About Lung Cancer Screening Which is More Appropriate to the Public? (ID 10686)

      06:00 - 06:00 PM  |  Presenting Author(s): Sam M Janes

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.42 - 4. Can we Implement International Standards for Quantitative CT Imaging within Lung Cancer? (ID 10687)

      06:00 - 06:00 PM  |  Presenting Author(s): David F Yankelevitz

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.43 - 5. How Can IASLC Lead Global Lung Cancer Progress Over the Next 10 Years? (ID 10688)

      06:00 - 06:00 PM  |  Presenting Author(s): Kwun M Fong

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 01.44 - Networking Dinner (ID 10689)

      06:00 - 09:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    WS 02 - IASLC Symposium on the Advances in Lung Cancer CT Screening (Ticketed Session) (ID 631)

    • Type: Symposium
    • Track: Radiology/Staging/Screening
    • Moderators:
    • +

      WS 02.01 - Welcome to the Special Symposium (ID 10583)

      09:00 - 09:10 AM  |  Presenting Author(s): Claudia I Henschke, Giulia Veronesi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.02 - Session 1: Status of Lung Cancer Screening in USA and Europe (ID 10584)

      09:10 - 09:10 AM  |  Presenting Author(s): Giulia Veronesi, Robert Smith

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.03 - Lung Cancer Screening – IELCAP Contribution to CT Screening Implementation (ID 10620)

      09:10 - 10:10 AM  |  Presenting Author(s): Claudia I Henschke  |  Author(s): Anthony Reeves, David F Yankelevitz

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.04 - Lung Cancer Screening Status in Europe (ID 10621)

      10:10 - 10:40 AM  |  Presenting Author(s): Giulia Veronesi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.05 - The European Commission Recommendations on Lung Cancer Screening (ID 10622)

      10:40 - 11:00 AM  |  Presenting Author(s): Denis Horgan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.06 - Group Discussion (ID 10623)

      11:00 - 11:30 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.07 - Tea/Coffee Break (ID 10585)

      11:30 - 12:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.08 - Session 2: Current Lung Cancer Screening Guidelines (Panel Discussion) (ID 10586)

      12:00 - 12:00 PM  |  Presenting Author(s): Claudia I Henschke, Javier J. Zulueta

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.09 - Lung Cancer Guidelines (ID 10624)

      12:00 - 01:00 PM  |  Presenting Author(s): Matthew Eric Callister, Stephen Lam, Sadayuki Murayama, John Kirkpatrick Field, David F Yankelevitz, Nasser Altorki

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.10 - Lunch (ID 10587)

      01:00 - 02:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.11 - Session 3: Early Detection Biomarkers (ID 10588)

      02:00 - 02:00 PM  |  Presenting Author(s): Luis M Montuenga, Nir Peled

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.12 - Lung Cancer Biomarkers - Do We Have Good Candidates for Early Detection? (ID 10625)

      02:00 - 02:30 PM  |  Presenting Author(s): Pierre P Massion

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.13 - New Approaches to Interventional Pulmonology for Lung Cancer Screening (ID 10626)

      02:30 - 03:00 PM  |  Presenting Author(s): Nir Peled

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.14 - The Airway Transcriptome (ID 10627)

      03:00 - 03:30 PM  |  Presenting Author(s): Avrum Spira

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.15 - Quality Control for Lung Imaging Biomarkers (ID 10628)

      03:30 - 04:00 PM  |  Presenting Author(s): Ricardo S Avila  |  Author(s): Claudia I Henschke, David F Yankelevitz

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.16 - Tea/Coffee Break (ID 10589)

      04:00 - 04:15 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.17 - Session 4: Lung Cancer Screening’s Impact on COPD and Smoking Cessation (ID 10590)

      04:15 - 04:15 PM  |  Presenting Author(s): Andrea Katalin Borondy Kitts, Kazuto Ashizawa

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.18 - Lung Cancer Screening and COPD – A Pneumologist’s Viewpoint (ID 10629)

      04:15 - 04:45 PM  |  Presenting Author(s): Javier J. Zulueta

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.19 - Tobacco Cessation in the CT Screening Setting – The Way Forward? (ID 10630)

      04:45 - 05:15 PM  |  Presenting Author(s): Jamie Ostroff

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.20 - Communicating Complex Issues Simply: Pivotal Role of Nursing in Lung Cancer Screening (ID 10631)

      05:15 - 06:00 PM  |  Presenting Author(s): Joelle Thirsk Fathi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 02.21 - Final Discussion (ID 10632)

      06:00 - 06:15 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West (ID 630)

    • Type: Joint Session IASLC/CSCO/CAALC
    • Track: Immunology and Immunotherapy
    • +

      JCSE 01.01 - Breakfast and Poster Viewing (ID 8221)

      07:30 - 07:55 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.02 - Welcome and Introduction (ID 8222)

      07:55 - 08:00 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.03 - The Science of Immunotherapy (ID 8220)

      08:00 - 08:20 AM  |  Presenting Author(s): Roy S. Herbst

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.05 - PD-1+CD8+ T and iNKT Cell Based Immunotherapy on Lung Cancer (ID 8224)

      08:20 - 08:40 AM  |  Presenting Author(s): Jianqing Xu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.06 - ctDNA Based Tumor Mutation Burden Evaluation for Predicting Immunotherapy Effect (ID 8225)

      08:40 - 09:00 AM  |  Presenting Author(s): Jie Hu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.07 - Ongoing Trials in China on Checkpoint Inhibitors and Other Immunotherapies (ID 8226)

      09:00 - 09:20 AM  |  Presenting Author(s): Qing Zhou

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.08 - Coffee Break and Poster Viewing (ID 8227)

      09:20 - 09:45 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.09 - Therapeutic Practices in Europe for Immunotherapy, including Biomarkers (ID 8228)

      09:45 - 10:05 AM  |  Presenting Author(s): Solange Peters

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.10 - The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer (ID 10904)

      10:05 - 10:20 AM  |  Presenting Author(s): Songtao Xu  |  Author(s): W. Zhong, Y. Zhang, W. Mao, L. Wu, Y. Shen, Y. Liu, C. Chen, Y. Cheng, L. Xu, J. Wang, K. Fei, X. Li, J. Li, C. Huang, Z. Liu, S. Xu, K. Chen, S. Xu, L. Liu, P. Yu, B. Wang, H. Ma, H. Yan, X. Yang, Yi-Long Wu, Q. Wang

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.11 - A Multicenter, Non-Interventional Study on Real World EGFR Testing and in Patients with IIIB/IV NSCLC in Northern China (ID 10905)

      10:20 - 10:35 AM  |  Presenting Author(s): Ying Cheng  |  Author(s): Y. Wang, J. Zhao, Y. Liu, H. Gao, K. Ma, S. Zhang, H. Xin, J. Liu, H. Chengbo, Z. Zhu, Y. Wang, J. Chen, F. Wen, J. Li, Z. Jie, Z. Zheng, Z. Dai, H. Piao, X. Li, Y. Li, M. Zhong, R. Ma, Y. Zhuang, Y. Xu, Z. Qu, H. Yang, C. Pan, F. Yang, D. Zhang, B. Li

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.12 - A Phase II Study of Fruquintinib in Combination with Gefitinib in Stage IIIb/IV NSCLC Patients Harboring EGFR Activating Mutations (ID 10907)

      10:35 - 10:50 AM  |  Presenting Author(s): Shun Lu  |  Author(s): J. Zhou, X. Niu, M. Chen, Y. Hua, W. Su

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.13 - Discussant Oral Abstracts - JCSE 01.10, JCSE 01.11, JCSE 01.12 (ID 10909)

      10:50 - 11:10 AM  |  Presenting Author(s): Joel W. Neal

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.14 - Discussant Poster Abstracts (ID 10908)

      11:10 - 11:30 AM  |  Presenting Author(s): Bob T. Li, Jonathan W Riess

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.15 - Next Generation Sequencing of Large-Cell Neuroendocrine Carcinoma Reveals an Association of PIK3CA Mutations with Brain Metastases (ID 10910)

      11:30 - 11:30 AM  |  Presenting Author(s): Mian Xie  |  Author(s): X. Wu, Y. Gu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.16 - Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer (ID 10911)

      11:30 - 11:30 AM  |  Presenting Author(s): Wenyu Sun  |  Author(s): K. Ma, X. Wang, Y. Liu, H. He, Y. Guo

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.17 - The Correlation of DLL3 Expression with High-Grade Pulmonary Neuroendocrine Carcinoma Clinicopathologic Features and Prognose (ID 10913)

      11:30 - 11:30 AM  |  Presenting Author(s): Li-Xu Yan  |  Author(s): Y. Liu, J. He, D. Luo

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.18 - Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients (ID 10914)

      11:30 - 11:30 AM  |  Presenting Author(s): Yun Fan  |  Author(s): K. Chen, X. Yu, H. Wang, Z. Huang, Y. Xu, L. Gong

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.19 - EGFR Mutation Correlates with Uninflamed Phenotype and Weak Immunogenicity, Causing Impaired Response to PD-1 Blockade in NSCLC (ID 10915)

      11:30 - 11:30 AM  |  Presenting Author(s): Zhong-Yi Dong  |  Author(s): W. Zhong, Yi-Long Wu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.20 - Primary Tumor Resection versus Maintenance Therapy for Patients with Oligometastatic Non-Small Cell Lung Cancer (ID 10916)

      11:30 - 11:30 AM  |  Presenting Author(s): Xiaozheng Kang  |  Author(s): H. Zhou, W. Yan, L. Dai, Y. Yang, H. Yang, H. Fu, M. Fan, Y. Lin, Z. Liang, H. Xiong, K. Chen

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.21 - Combination of Biomarker and Clinicopathologic Characters May Circle out Beneficiaries through Second-Line Immunotherapy: A Meta Analyse (ID 10917)

      11:30 - 11:30 AM  |  Presenting Author(s): Si-Yang Liu  |  Author(s): Z. Dong, C. Zhang, W. Zhong, Yi-Long Wu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.22 - Is Preoperative EGFR-TKI Comparable with Chemotherapy for Stage II-IIIA Lung Adenocarcinoma? (ID 10918)

      11:30 - 11:30 AM  |  Presenting Author(s): Chao Lyu  |  Author(s): F. Lu, Y. Ma, S. Li, L. Zhang, Y. Yang

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.23 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study (ID 10919)

      11:30 - 11:30 AM  |  Presenting Author(s): Lucheng Zhu  |  Author(s): S. Zhang, B. Xia, X. Chen, S. Ma

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.24 - Detection of EGFR, ALK and Other Driver Oncogenes from Plasma cfDNA by Single Molecule Amplification and Re-sequencing Technology (cSMART) (ID 10920)

      11:30 - 11:30 AM  |  Presenting Author(s): Tony SK Mok  |  Author(s): Shun Lu, Y. Cheng, Jie Wang, Y. Wang, T. Wang, T. Yung, X. Su, F. Sun, F. Sun, L.T. Wang, Yi-Long Wu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.25 - Detection of EGFR T790M Mutations by Four Testing Platforms in ctDNA from Chinese Patients with Advanced NSCLC (ID 10921)

      11:30 - 11:30 AM  |  Presenting Author(s): Xu-Chao Zhang  |  Author(s): Z. Liang, Y. Chen, H. Zhang, W. Gang, Y. Lu, Z. Liang, Y. Cheng, Y. Hu, Jie Wang, J. Ying, W. Liu, Yi-Long Wu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.26 - Circulating Cell-Free DNA of Cerebrospinal Fluid May Function as Liquid Biopsy for Leptomeningeal Metastases of ALK Rearrangement NSCLC (ID 10922)

      11:30 - 11:30 AM  |  Presenting Author(s): Yangsi Li  |  Author(s): B. Jiang, Jin -Ji Yang, X. Zhang, Z. Zhang, Qing Zhou, H. Tu, Z. Wang, H. Chen, C. Xu, B. Wang, Yi-Long Wu

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.27 - Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial (ID 10923)

      11:30 - 11:30 AM  |  Presenting Author(s): Tony SK Mok  |  Author(s): Solange Peters, D. Ross Camidge, Shirish M Gadgeel, S.I. Ou, D. Kim, Rafal Dziadziuszko, F. De Marinis, R. Sangha, A. Zeaiter, J. Noe, E. Nueesch, T. Liu, I. Loftin, C. Williams, Alice Shaw

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.28 - NGS Sequencing Based Liquid / Tissue Biopsy Identified Coexistence of HER2 Amplification and Mutation in Advanced NSCLC Patients (ID 10924)

      11:30 - 11:30 AM  |  Presenting Author(s): Rongrong Chen  |  Author(s): J. Zhao, G. Lin, L. Liu, L. Chen, X. Hu, X. Ai, Z. Fan, C. Xu, W. Wang, W. Zhuang, M. Fang, Y. Zhu, G. Chen, Y. Guan, L. Yang, X. Xia, X. Yi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      JCSE 01.29 - Closing Remarks (ID 8230)

      11:30 - 11:30 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    YI 01 - Young Investigator and First Time Attendee Session (ID 588)

    • Type: Young Investigator
    • Track: Education/Publication/Career Development
    • +

      YI 01.01 - Introduction to IASLC: What It Can Do For You (ID 7845)

      08:00 - 08:10 AM  |  Presenting Author(s): Silvia Novello

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.02 - Planning an Academic Career in Lung Cancer (ID 7846)

      08:10 - 08:25 AM  |  Presenting Author(s): Navneet Singh

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.03 - Community versus Academic Oncology (ID 7847)

      08:25 - 08:40 AM  |  Presenting Author(s): Philip Bonomi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.04 - Clinical Trials 101 (ID 7848)

      08:40 - 08:55 AM  |  Presenting Author(s): Julie R Brahmer

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.05 - Investigator Initiated Trials (ID 7849)

      08:55 - 09:10 AM  |  Presenting Author(s): Daniel SW Tan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.06 - Coffee Break (ID 8130)

      09:10 - 09:40 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.07 - How to Get Your Paper Published (ID 7850)

      09:40 - 09:55 AM  |  Presenting Author(s): Alex Adjei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.08 - Why Should I Publish? An Overview of the Manuscript Cycle: From Submission to Publication (ID 7851)

      09:55 - 10:10 AM  |  Presenting Author(s): Jim Jett

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.09 - How to Prepare an Abstract for an International Conference and How to Prepare Your Presentation for the Conference (Tips and Tricks) (ID 7852)

      10:10 - 10:25 AM  |  Presenting Author(s): Michael Boyer

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.10 - How to Write a Grant Application for Young Investigators (ID 7853)

      10:25 - 10:40 AM  |  Presenting Author(s): Heather A Wakelee

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.11 - The Young Investigator Travel Award Experience - A Report from a Previous Award Winner (ID 7854)

      10:40 - 10:45 AM  |  Presenting Author(s): Takahiro Karasaki

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.12 - Making the Most of the WCLC: A Guide for First Time Attendee - From an Expert Perspective (ID 7855)

      10:45 - 11:00 AM  |  Presenting Author(s): Suresh Senan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.13 - Making the Most of the WCLC: A Guide for First Time Attendee - From a Second Time Attendee (ID 7856)

      11:00 - 11:05 AM  |  Presenting Author(s): Deepali Jain

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      YI 01.14 - Q&A (ID 11027)

      11:05 - 11:30 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    SS 01 - Supporting the Clinical Management of Lung Cancer Patients through Innovation in Diagnostics - Roche (ID 761)

    • 08:15 AM - 12:00 PM
    • 10/15/2017
    • Location: Room 315
    • Moderators:
    • +

      SS 01.01 - Welcome & Opening (ID 10968)

      08:15 - 08:30 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.02 - Unmet Medical Needs and Challenges in Lung Cancer Patient Management - A Pulmonologists Perspective (ID 10969)

      08:30 - 08:47 AM  |  Presenting Author(s): Ramon Marrades

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.03 - Protein-based Biomarkers as Tools to Support Clinical Decision Making with Results from the Laboratory (ID 10970)

      08:47 - 09:05 AM  |  Presenting Author(s): Rafael Molina

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.04 - Panel - Q&A (ID 10971)

      09:05 - 09:20 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.05 - Break (ID 10972)

      09:20 - 09:35 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.06 - Integrated Tissue and Molecular Diagnostics for Optimal Lung Cancer Patient Care (ID 10973)

      09:35 - 10:10 AM  |  Presenting Author(s): Stephen P Finn

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.07 - The Evolution of Lung Cancer Treatment - Clinical Impact of Genomic Alterations Detected in Tissue and Plasma (ID 10974)

      10:10 - 10:45 AM  |  Presenting Author(s): Alice Shaw

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.08 - Clinical Utility of Liquid Biopsy in Managing NSCLC Patients - Performance and Impact on Clinical Decisions (ID 10975)

      10:45 - 11:20 AM  |  Presenting Author(s): Shobhit Baijal

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.09 - Panel - Q&A (ID 10976)

      11:20 - 11:50 AM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      SS 01.10 - Wrap-up & Closing (ID 10977)

      11:50 - 12:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    ISS 01 - Treatment Options for Patients with ALK+ NSCLC: How is the Paradigm Changing? - Takeda Oncology (ID 634)

    • +

      ISS 01.01 - Welcome and Introduction (ID 10615)

      11:30 - 11:35 AM  |  Presenting Author(s): Tony SK Mok, D. Ross Camidge

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 01.02 - Long-term Survival for Patients with ALK+ NSCLC: An Achievable Aim? (ID 10617)

      11:35 - 11:55 AM  |  Presenting Author(s): Tony SK Mok

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 01.03 - Treating Patients with ALK+ NSCLC: What Are the Unmet Needs? (ID 10616)

      11:55 - 12:15 PM  |  Presenting Author(s): D. Ross Camidge

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 01.04 - Testing Resistant ALK+ NSCLC: Can Treatment Be Personalised? (ID 10618)

      12:15 - 12:35 PM  |  Presenting Author(s): Maurice Pérol

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 01.05 - Panel Discussion and Questions from the Audience (ID 10963)

      12:35 - 12:50 PM  |  Presenting Author(s): Tony SK Mok, D. Ross Camidge, Maurice Pérol

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 01.06 - Summary and Conclusions (ID 10619)

      12:50 - 01:00 PM  |  Presenting Author(s): Tony SK Mok, D. Ross Camidge

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    WS 03 - ITONF Lung Cancer and Mesothelioma Workshop (Ticketed Session) (ID 751)

    • 12:15 PM - 05:55 PM
    • 10/15/2017
    • Location: Room 313
    • Moderators:
    • +

      WS 03.01 - ITONF Members Meeting (with Lunch) (ID 10881)

      12:15 - 01:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.02 - Local Therapies for Lung Cancer and Mesothelioma (ID 10946)

      01:00 - 01:00 PM  |  Presenting Author(s): Caitlin Broderick

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.03 - Welcome Address (ID 10882)

      01:00 - 01:05 PM  |  Presenting Author(s): Beth Ivimey

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.04 - The Oncology Nurse Role in the Treatment of Lung Cancer and Mesothelioma: The Recent Practice in Japan (ID 10883)

      01:05 - 01:30 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.05 - Explaining Radiation Treatments in Lung Cancer (ID 10884)

      01:30 - 01:50 PM  |  Presenting Author(s): Mary Duffy

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.06 - Local Treatments for Lung Cancer – Blade vs Beam: A Debate (ID 10885)

      01:50 - 02:20 PM  |  Presenting Author(s): David L Ball, Melissa Culligan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.07 - Wellness and Supportive Care for Lung Cancer and Mesothelioma Patients (ID 10947)

      02:20 - 02:20 PM  |  Presenting Author(s): Kathleen Ann Gamblin

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.08 - Acute Thoracic Oncology Nursing (ID 10887)

      02:20 - 02:40 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.09 - Living Well with Lung Cancer and Mesothelioma (ID 10888)

      02:40 - 03:00 PM  |  Presenting Author(s): Pippa Labuc

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.10 - Panel Discussion (ID 10889)

      03:00 - 03:10 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.11 - Break (ID 10890)

      03:10 - 03:25 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.12 - Systemic Treatments for Lung Cancer and Mesothelioma (ID 10948)

      03:25 - 03:25 PM  |  Presenting Author(s): Massey Nematollahi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.13 - Targeted Therapies: Toxicities Management and Care (ID 10891)

      03:25 - 03:50 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.14 - Targeted Therapies: Case Studies and Experience from Different Regions Q&A (ID 10892)

      03:50 - 04:15 PM  |  Presenting Author(s): Beth Ivimey, Caitlin Broderick, Beth Eaby-Sandy, John McPhelim

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.15 - Immuno-oncology Overview (ID 10893)

      04:15 - 04:35 PM  |  Presenting Author(s): Marianne Davies

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.16 - Japan’s Challenges in Immunotherapy for Lung Cancer as a Pioneer: The Nurses View (ID 10894)

      04:35 - 04:55 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.17 - Latest Advances in the Treatment of Malignant Pleural Mesothelioma (ID 10895)

      04:55 - 05:20 PM  |  Presenting Author(s): Mary Hesdorffer

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.18 - Mesothelioma Online Educational Programs, ITONF Nurse Education Programs & N&AH Immunotherapy Guidelines Launch (ID 10896)

      05:20 - 05:55 PM  |  Presenting Author(s): Melissa Culligan, Liz Darlison, Anne Fraser, Kathleen Ann Gamblin

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 03.19 - Close (ID 10886)

      05:55 - 05:55 PM  |  Presenting Author(s): Melissa Culligan

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    WS 04 - Minimally Invasive Diagnosis and Staging of Lung Cancer – Interventional Pulmonology Hands-On Workshop (Ticketed Session) (ID 766)

    • Type: Workshop
    • Track: Pulmonology/Endoscopy
    • Moderators:
    • +

      WS 04.01 - Welcome and Introduction (ID 11036)

      01:00 - 01:10 PM  |  Presenting Author(s): Kazuhiro Yasufuku

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.02 - EBUS-TBNA – Role in Invasive Mediastinal Staging (ID 11037)

      01:10 - 01:30 PM  |  Presenting Author(s): Kazuhiro Yasufuku

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.03 - Specimen Acquisition and Processing (ID 11038)

      01:30 - 01:50 PM  |  Presenting Author(s): Takahiro Nakajima

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.04 - Radial Probe EBUS – Methods and Results (ID 11039)

      01:50 - 02:10 PM  |  Presenting Author(s): Takehiro Izumo

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.05 - Navigational Bronchoscopy (ID 11040)

      02:10 - 02:30 PM  |  Presenting Author(s): L. Donahoe

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.06 - Hands-On Session (5 work stations) (ID 11041)

      02:30 - 05:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.07 - 1. EBUS-TBNA (ID 11042)

      05:00 - 05:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.08 - 2. Radial Probe EBUS (ID 11043)

      05:00 - 05:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.09 - 3. Specimen Handling (ID 11044)

      05:00 - 05:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.10 - 4. Navigational Bronchoscopy (Super Dimension) (ID 11045)

      05:00 - 05:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      WS 04.11 - 5. Navigational Bronchoscopy (BF Navi) (ID 11046)

      05:00 - 05:00 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    ISS 02 - Treatment Selection Strategies in Advanced NSCLC – Implications and Global Perspectives - Lilly Oncology (ID 635)

    • +

      ISS 02.01 - Welcome & Introduction (ID 10633)

      03:00 - 03:05 PM  |  Presenting Author(s): N. Thatcher, Kazuhiko Nakagawa

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 02.02 - Increasing Complexity of Therapeutic Decision-Making for Advanced NSCLC (ID 10634)

      03:05 - 03:25 PM  |  Presenting Author(s): David R. Gandara

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 02.03 - How Long Do I Treat? When to Stop? Implications for Clinical Practice (ID 10635)

      03:25 - 03:40 PM  |  Presenting Author(s): Silvia Novello

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 02.04 - Illustrative and Interactive Case Study Discussions (ID 10636)

      03:40 - 04:10 PM  |  Presenting Author(s): Oscar Arrieta, Myung-Ju Ahn, Hidehito Horinouchi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 02.05 - Global Perspectives on the Changing Treatment Paradigm in Advanced NSCLC (ID 10637)

      04:10 - 04:20 PM  |  Presenting Author(s): James Chih-Hsin Yang

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 02.06 - Panel Discussion (ID 10638)

      04:20 - 04:30 PM  |  Presenting Author(s): N. Thatcher, Kazuhiko Nakagawa

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 02.07 - Symposium Closes (ID 10639)

      04:30 - 04:30 PM

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

  • +

    ISS 03 - Management of Advanced NSCLC: Where Do Immune Checkpoint Inhibitors Fit In? - Medscape - Supported by Independent Educational Grant from AstraZeneca Pharmaceuticals LP (ID 636)

    • +

      ISS 03.01 - Welcome and Introductions (ID 10690)

      04:45 - 04:50 PM  |  Presenting Author(s): Hossein Borghaei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.02 - Where Do Checkpoint Inhibitors Fit in Second-Line Therapy? (ID 10691)

      04:50 - 05:05 PM  |  Presenting Author(s): Fabrice Barlesi

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.03 - Where Do Checkpoint Inhibitors Fit in First-Line Therapy? (ID 10692)

      05:05 - 05:20 PM  |  Presenting Author(s): Edward Brian Garon

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.04 - The Immune Effects of Immune Checkpoint Inhibitors: ir-AEs (ID 10693)

      05:20 - 05:35 PM  |  Presenting Author(s): Hossein Borghaei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.05 - Double, Double, Toil and Trouble With Combination Therapy? (ID 10694)

      05:35 - 05:50 PM  |  Presenting Author(s): Edward Brian Garon

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.06 - The Future of Checkpoint Inhibitors in Your Practice (ID 10695)

      05:50 - 06:00 PM  |  Presenting Author(s): Hossein Borghaei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.07 - Concluding Remarks (ID 10696)

      06:00 - 06:05 PM  |  Presenting Author(s): Hossein Borghaei

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review

    • +

      ISS 03.08 - Question and Answer Session (ID 10697)

      06:05 - 06:15 PM  |  Presenting Author(s): Hossein Borghaei, Fabrice Barlesi, Edward Brian Garon

      • Abstract

      The abstract for this presentation will be made available after embargo. Please return after this date to review